Insufficient therapeutic management of hypertensive patients with renal failure in France

Archives of Cardiovascular Diseases

Volumn 101, Issue 11-12, 2008, Pages 705-713

  P Guérin, Alain ^a   Maumus Robert, Sandy ^b   Zin, Adeline ^b  

^a Centre Hospitalier Manhes   (France)

^b Clinsearch ^*  (France)

Author keywords

Angiotensin receptor blocker; Angiotensin converting enzyme inhibitor; Chronic renal failure; Hypertension; Microalbuminuria; Proteinuria

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; DISEASE SEVERITY; FEMALE; FRANCE; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT CARE; RISK FACTOR;

EID: 58049198082     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2008.09.007     Document Type: Article

References (28)

1. Réseau, Épidémiologie, Information, Néphrologie [REIN]. Registre français des traitements de suppléance de l'insuffisance rénale chronique. Agence de la Biomédecine. Rapport annuel; 2006.
2. Laville M. Hypertension and renal insufficiency. Arch Mal Coeur Vaiss 2000;93:1459-68.
3. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
4. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
5. Guidelines committee. European Society of Hypertension. European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
6. The Work group members. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43:S1-290.
7. HAS. Prise en charge des patients adultes atteints d'hypertension artérielle essentielle. Actualisation 2005. Recommandations professionnelles; 2005.
8. ANAES. Moyens thérapeutiques pour ralentir la progression de l'insuffisance rénale chronique chez l'adulte. Paris: ANAES; 2004.
9. Chanard J. Chronic renal failure and hypertension in community cardiology practice. Presse Med 2001; 30:1288-94.
10. Mounier-Vehier C, Amah G, Duquenoy S, et al. Is assessment of kidney involvement in patients with essential hypertension satisfactory? General medical observation results in a national study (PHENOMEN). Arch Mal Coeur Vaiss 2003;96:792-5.
11. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987;3:1098.
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
13. ANAES. Diagnostic de l'insuffisance rénale chronique chez l'adulte. ANAES/Service des recommendations et références professionnelles; 2002.
14. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease. Stud Kidney Int 1997;51:1908-19.
15. Jungers P, Hannedouche T, Itakura Y, et al. Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors. Nephrol Dial Transplant 1995;10:1353-60.
16. Jungers P, Choukroun G, Robino C, et al. Epidemiology of end-stage kidney failure in the Île-de-France: a prospective cooperative study in 1998. Nephrologie 2000;21:239-46.
17. Kessler M. Value of early management of patients with chronic renal failure. Presse Med 1997;26:1340-2.
18. Chantrel F, Enache I, Bouiller M, et al. Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol Dial Transplant 1999; 14:129-36.
19. Bourel M, Ardaillou R. Prevention and screening of chronic renal failure. Bull Acad Natl Med 2004;188:1455-68.
20. Couchoud C, Stengel B, Landais P, et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant 2006;21:411-8.
21. Couchoud C, Stengel B, Jacquelinet C. REIN annual report 2005. Renal Epidemiology and Information Network Et Agence de ta biomédecine. Nephrol Ther 2007;Suppl. 1: S1-82.
22. Drey N, Roderick P, Mullee M, et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003;42:677-84.
23. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47.
24. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47.
25. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
26. Tilly B, Salavane B, Ricordeau Ph, Bertin N, Guilhot J, Fender P, et al. Hypertension artérielle sévère en France: traitement et contrôle tensionnel en 1999 et 2003. Rev Med Assess Mal 2004; 35:167-80.
27. Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2001; 161:1207-16.
28. Guerin A, Savary OM, Del Puppo S. MIRA study: epidemiology of microalbuminuria in type 2 diabetes patients and associated comorbidities. Arch Mal Coeur Vaiss 2005;98:783-7.